

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+1.46%
+4.00%
+1.50%
+2.86%
-1.82%
MIRA
MIRA Pharmaceuticals Inc.
$1.56
Strengths

Outperform the market
Chart
$1.32 (+18.18%)
$1.69 (-7.69%)
$1.38 (+13.04%)
$1.26 (+23.81%)
MIRA has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Price under $5

MIRA overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Outperform the market
![]()
MIRA Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
MIRA Street view is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayMIRA Earnings
The TTM reflects 12-month period, providing review of MIRA financial performance.
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
What is MIRA current stock price?
What are MIRA stock strengths?
What risks are associated with MIRA stock?
When is MIRA next earnings report?
What is MIRA market cap and volume?
What is MIRA's current Stock IQ?
Should I buy MIRA stock right now?
Is MIRA a Strong Buy right now?
What does a 'Strong Buy' rating mean for MIRA?
What does a 'Strong Sell' rating mean for MIRA?
What factors influence MIRA's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+1.46%
+4.00%
+1.50%
+2.86%
-1.82%
MIRA
MIRA Pharmaceuticals Inc.
Current Price
$1.56
Chart
$1.32 (+18.18%)
$1.69 (-7.69%)
$1.38 (+13.04%)
$1.26 (+23.81%)
MIRA Analysts Opinion
MIRA Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Outperform the market
![]()
MIRA Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
MIRA Street view is extremely bullish and have positive views on the near-term outlook
MIRA has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Price under $5

Average key support and resistance price levels.
MIRA Earnings
The TTM data reflects the most recent 12-month period, providing overview of MIRA financial performance.
MIRA Financial Health
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
MIRA Latest Analysis
MIRA Pharmaceuticals Stock Surges Following Positive Preclinical Data. MIRA) shares are trading significantly higher on Thursday following the announcement of new preclinical data for its .Using pain sensitivity testing and inflammation measurements oral Mira-55 restored pain responses to baseline levels and directly reduced inflammation outperforming injected morphine. Morphine provided only partial pain relief and showed only indirect inflammation reduction through central mechanisms.The study
Thu Oct 16, 2025
Why J.B. Hunt Transport Shares Are Trading Higher By 13%. Here Are 20 Stocks Moving Premarket. Shares of JBHT) rose sharply in pre-market trading after the company beat third-quarter expectations on the top and bottom lines.The company reported quarterly earnings of $1.76 per share which beat the consensus estimate of $1.47. Quarterly revenue came in at $3.05 billion which beat the Street estimate of $3.02 billion.J.B. Hunt Transport shares jumped 12.9% to $156.80 in the pre-market trading sessi
Thu Oct 16, 2025
Why Mira Pharmaceuticals Shares Rose 69% After Hours?. MIRA) shares jumped 68.94% to $2.23 in after-hours trading on Wednesday.Check out the current price of MIRA stock here.On Wednesday Mira Pharmaceuticals submitted an 8-K filing with the The study found that orally administered Mira-55 reduced inflammation and normalized pain levels outperforming injected morphine in an animal model of chronic inflammatory pain.In preclinical studies oral Mira-55 was shown to restore pain sensitivity to norma
Thu Oct 16, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
MIRA Stock trends
MIRA Stock performance
MIRA Stock analysis
MIRA investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.